Oxidative Stress Clinical Trial
Verified date | March 2017 |
Source | Ain Shams University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of the present study is to test a hypothesis assuming that phototherapy might have an effect on oxidant/antioxidant status in term and late-preterm neonates with unconjugated hyperbilirubinemia.
Status | Active, not recruiting |
Enrollment | 120 |
Est. completion date | March 2017 |
Est. primary completion date | March 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A to 28 Days |
Eligibility |
Inclusion Criteria: - Term and late-preterm neonates (=35weeks) according to the guidelines of the American Academy of Pediatrics (2004) which stated that gestational ages of newborns were determined according to the first day of the mother's last menstrual period (by the mother's statement) and were additionally confirmed by the Ballard scoring system (Ballard et al., 1991) and antenatal ultrasonographic estimation or obstetric records if present. - Clinical significant indirect hyperbilirubinemia requiring phototherapy in the first week of life. - Normal blood counts and peripheral blood smears - Normal reticulocytic count. - Breast fed newborn. Exclusion Criteria: - Those in whom the total serum bilirubin (TSB) level rose by more than 5 mg/dl per day or was higher than 20 mg/dl within the first 24 hours after birth were excluded from the study. - Infant of diabetic mothers. - Maternal eclampsia-preeclampsia. - Birth asphyxia - Sepsis - congenital anomalies. - Direct Coombs`test positive - Pathological causes of hyperbilirubinemia. - Enclosed hemorrhage. - Hemolytic type of hyperbilirubinemia due to blood group or Rh incompatibility. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Rania Ali El-Farrash |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Effect of types of phototherapy on change in total antioxidant capacity (TAC) | This will be determined by: Measure TAC (mmol/L) before and after phototherapy Compare results of TAC (mmol/L) before and after phototherapy. |
2 days | |
Primary | Effect of types of phototherapy on change in malonaldehyde (MDA) | This will be determined by: Measure MDA (nmol/L) before and after phototherapy Compare results of MDA (nmol/L) before and after phototherapy. |
2 days | |
Primary | Effect of types of phototherapy on change in nitric oxide (NO) | This will be determined by: Measure NO (umol/L) before and after phototherapy Compare results of NO (umol/L) before and after phototherapy. |
2 days | |
Secondary | Effect of types of phototherapy on change in serum iron (Fe) | This will be determined by: Measure serum Fe before and after phototherapy Compare results of serum Fe before and after phototherapy. |
2 days | |
Secondary | Effect of types of phototherapy on change in serum copper (Cu) | This will be determined by: Measure serum Cu before and after phototherapy Compare results of serum Cu before and after phototherapy. |
2 days | |
Secondary | Effect of types of phototherapy on change in serum zinc (Zn) | This will be determined by: Measure serum Zn before and after phototherapy Compare results of serum Zn before and after phototherapy. |
2 days | |
Secondary | Effect of types of phototherapy on change in serum calcium (Zn) | This will be determined by: Measure serum Ca before and after phototherapy Compare results of serum Ca before and after phototherapy. |
2 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03255187 -
Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution
|
N/A | |
Completed |
NCT04136821 -
The Long-term Effects of Oceanix™ on Resistance Training Adaptations
|
N/A | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Completed |
NCT03358524 -
Effects of Vitamin E Supplementation on Free Radicals and Fat Level of Obese Adolescence in Jakarta, Indonesia
|
Phase 4 | |
Recruiting |
NCT05327348 -
Effectiveness of IV Vitamin C in Reducing Oxidative Stress Associated With Free Flap Surgery
|
Phase 3 | |
Completed |
NCT03288623 -
The Effects of Dark Chocolate Implementation in Elite Athletes
|
N/A | |
Completed |
NCT04419025 -
Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease
|
Phase 2 | |
Completed |
NCT04597983 -
Effect of 8-week Intake of 2S-hesperidin on Performance, Body Composition and Biochemicals Markers in Amateur Cyclists
|
N/A | |
Not yet recruiting |
NCT06159543 -
The Effects of Fresh Mango Consumption on Cardiometabolic Outcomes in Free-living Individuals With Prediabetes
|
N/A | |
Enrolling by invitation |
NCT03030456 -
Whole Body Vibrations on Functional Capacity, Muscular Strength, and Biochemical Profile in Elders
|
N/A | |
Completed |
NCT02256254 -
SIMOX - Induction of Oxidative Stress
|
Phase 2 | |
Not yet recruiting |
NCT02202239 -
Effect of Induction and Maintenance of Anesthesia With Etomidate on Hemodynamics and Oxidative Stress in Diabetic Patients
|
Phase 4 | |
Recruiting |
NCT02048592 -
Impact of Immunonutrition on the Patients With Cystic Fibrosis
|
Phase 4 | |
Completed |
NCT01942460 -
Ferumoxytol for Iron-Deficiency Anemia in Chronic Kidney Disease and Peritoneal Dialysis Patients
|
Phase 4 | |
Completed |
NCT02463318 -
The Effect of Melatonin on Gene Expression and Activity of the Sirt1 and Its Target Genes Catalase and MnSOD in Multiple Sclerosis Patients and Healthy Subjects
|
N/A | |
Completed |
NCT02177383 -
Action of Essential Fatty Acids on the Expression of Antioxidant Genes and Athletic Performance
|
N/A | |
Completed |
NCT01990391 -
Brazil Nut Consumption in Microvascular Endothelial Function, Oxidative Stress and Metabolic Abnormalities
|
N/A | |
Completed |
NCT00845130 -
Quantitative in Vivo Biomarkers of Oxidative Stress in Diabetes
|
N/A | |
Completed |
NCT00607893 -
Efficacy of Continuous Positive Airway Pressure in Reducing Oxidative Stress in Individuals With Sleep Apnea
|
N/A | |
Active, not recruiting |
NCT00247507 -
The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients
|
Phase 4 |